Introduction
Trichinellosis is a prevalent zoonotic disease affecting multiple mammals, such as pigs, mice, and humans. Trichinellosis is mainly attributed to Trichinella spiralis (T. spiralis) (Bai et al. Reference Bai, Hu, Liu, Tang and Liu2017). Humans contract infection through the accidental ingestion of encysted T. spiralis larvae found in undercooked pork meat or pork products (Rainova et al. Reference Rainova, Kaftandjiev, Harizanov, Tsvetkova, Jordanova, Marinova, Kurdova, Kantardjiev and Lalkovski2016). Millions of individuals globally are affected, with an increasing risk of outbreaks (Muñoz-Carrillo et al. Reference Muñoz-Carrillo, Maldonado-Tapia, López-Luna, Muñoz Escobedo, Flores de la Torre and Moreno Garcìa2018). The life cycle of T. spiralis is characterized by its occurrence within a single host, featuring two distinctive intracellular habitats: enterocytes and muscle cells. Following ingesting infected meat, gastric juices digest muscle tissues and release larvae. After four molts, larvae become adults within small intestine enterocytes (Othman et al. Reference Othman, Abou Rayia, Ashour, Saied, Zineldeen and El-Ebiary2016). Newborn larvae convert striated muscle cells into nurse cells that can survive for years (Nassef et al. Reference Nassef, Moharm, Atia, Brakat, Abou hussien and Shamseldeen2019). The manifestations of trichinellosis vary according to the stage of the infection. The intestinal phase is characterized by diarrhea and abdominal discomfort. The muscle (or parenteral) phase is characterized by muscle pain, weakness, and symmetrical periorbital or facial edema (Huang et al. Reference Huang, Yao, Liu, Yang, Wang, Shi, Jiang, Wang, Kang, Wang, Wang and Yang2020).
Benzimidazoles serve as the principal pharmacological agents for the treatment of trichinellosis in both humans and animals. Nonetheless, these drugs exhibit several limitations, as none can effectively eradicate encapsulated larvae. This is due to their limited bioavailability and medication resistance (Caner et al. Reference Caner, Döşkaya, Değirmenci, Can, Baykan, Uner, Başdemir, Zeybek and Gürüz2008; Nassef et al. Reference Nassef, Moharm, Atia, Brakat, Abou hussien and Shamseldeen2019; Shalaby et al. Reference Shalaby, Moghazy, Shalaby and Nasr2010). Furthermore, most benzimidazole derivatives are contraindicated for use during pregnancy and in children under the age of two (Yadav and Temjenmongla Reference Yadav and Temjenmongla2012). Consequently, a significant demand exists for effective anthelmintic agents targeting T. spiralis, particularly those derived from natural compounds. The World Health Organization encourages researchers to develop novel, safe anthelmintic agents that exhibit fewer adverse effects (Fahmy et al. Reference Fahmy, Zalat and Rabei2021). Medicinal plants are recognized for their efficacy as treatments, offering greater viability and reduced side effects compared to synthetic antihelminthic drugs (Batiha et al. Reference Batiha, Alkazmi, Wasef, Beshbishy, Nadwa and Rashwan2020).
Allium sativum (A. sativum) is a bulbous plant classified within the genus Allium and the family Liliaceae. Historically, it has functioned as a treatment for various ailments (Timothée Kouassi et al. Reference Timothée Kouassi, So, Abdou, saidou, Karim and Bakasso2021). Allicin is the main bioactive component of garlic. It is present in raw garlic homogenate or aqueous extract. Chopping garlic activates the alliinase enzyme, leading to the conversion of alliin into allicin (Bayan et al. Reference Bayan, Koulivand and Gorji2014). A. sativum has demonstrated effectiveness against various parasites, such as Schistosoma mansoni (Fakahany et al. Reference Fakahany, Abdelmaabood, Hamid, Morsi and Abououf2020), Giardia (Yousef et al. Reference Yousef, sanad, Abo El Maaty and Farag2022), and Hymenolepis nana (Soffar and Mokhtar Reference Soffar and Mokhtar1991). It was also found to be effective in the treatment of trypanosomiasis, leishmaniasis (Krstin et al. Reference Krstin, Sobeh, Braun and Wink2018) and cryptosporidiosis (Farid et al. Reference Farid, Yousry and Safwat2022). This antiparasitic efficacy has been attributed to the key component of A. sativum, allicin (Bayan et al. Reference Bayan, Koulivand and Gorji2014). A. sativum has also been recommended as a potent immunostimulant and therapeutic agent for various diseases. It demonstrated efficacy against various viruses, bacteria, and fungi (Arreola et al. Reference Arreola, Quintero-Fabián, López-Roa, Flores-Gutiérrez, Reyes-Grajeda, Carrera-Quintanar and Ortuño-Sahagún2015; Bayan et al. Reference Bayan, Koulivand and Gorji2014).
This research assessed the antiparasitic, anti-inflammatory, and antiapoptotic effects of a garlic-based product (Tomex Plus®) against experimental trichinellosis.
Material and methods
Animals
Fifty laboratory-bred Swiss albino male mice, aged 5 to 6 weeks and weighing between 20 and 25 grams, were used. They were obtained from the Theodor Bilharz Research Institute’s Biology Supply Center (TBRI) in Giza, Egypt, and maintained in accordance with institutional and national protocols.
Parasites
The utilized T. spiralis strain was supplied by TBRI (Parasitology Department).
Dose of infection
Each mouse received an oral inoculation of 200–250 T. spiralis larvae (Abou Rayia et al. Reference Abou Rayia, Saad, Ashour and Oreiby2017).
Experimental grouping
Five groups of mice (10 mice each) were created. GI: the negative control group (healthy normal control); GII: the positive control (infected and untreated); GIII: infected and received ABZ; GIV: infected and administered A. sativum (Tomex Plus®); and GV: infected and treated with a combination of ABZ and A. sativum.
Mice in Groups II–V were further divided into subgroups A and B, each comprising five mice. Subgroups A were designated for the study of the intestinal (enteral) phase, with mice sacrificed on the 7th day post-infection (dpi), while subgroups B were allocated for the examination of the muscular (parenteral) phase, with mice sacrificed on the 40th dpi.
Drugs
ABZ was provided as a suspension, 20 mg/mL (Alzental®, EIPICO, Egypt). For subgroups (A), it was administered at a daily oral dose of 50 mg/kg starting from the 3rd dpi for three consecutive days. Subgroups (B) were administered ABZ for seven consecutive days, starting from the 31st dpi (Attia et al. Reference Attia, Mahmoud, Farrag, Makboul, Mohamed and Ibraheim2015).
A. sativum was administered in 200 mg tablet form (Tomex Plus®, SEKEM, Egypt) at a dose of 20 mg/kg/day from the 1st dpi to the day of sacrifice (Sharafeldin et al. Reference Sharafeldin, Zowail and Abdelkareim2005). According to the manufacturer, Tomex Plus® is a powder of dried garlic bulbs standardized to contain at least 0.45% of allicin.
Parasitological examination
T. spiralis adult worm count
Mice in subgroups (A) were euthanized on the 7th dpi to assess the intestinal phase. The small intestine was excised, washed, and sectioned into small fragments. The specimens were subsequently immersed in normal saline for 3 to 4 hours at 37°C to facilitate the sedimentation of T. spiralis adult worms. Following the removal of the supernatant, the sediment was transferred to a petri dish and analyzed for adult worms using a dissecting microscope (Basyoni and El-Sabaa Reference Basyoni and El-Sabaa2013). The percentage reduction in T. spiralis adult worm count was calculated using the following equation:
T. spiralis larval count
Mice in subgroups (B) were sacrificed on the 40th dpi to assess the muscle phase. Each mouse was dissected and chopped into small pieces, and then dissolved in 200 mL of distilled water containing 1% pepsin hydrochloride for digestion. The mixture was incubated for two hours at 37°C with continuous electromagnetic stirring. The larvae were obtained using the sedimentation technique and subsequently rinsed with distilled water until the liquid was clear. The supernatant was removed, and the larvae in the sediment were enumerated microscopically with a McMaster counting chamber (Mayer-Scholl et al. Reference Mayer-Scholl, Pozio, Gayda, Thaben, Bahn and Nöckler2017). The percentage reduction in the number of T. spiralis larvae was calculated using the following equation:
Determination of serum IFN-γ levels
The serum was obtained by allowing collected blood samples to clot for 2 hrs at room temperature. Subsequently, samples underwent centrifugation at 2000×g for a duration of 20 min. Serum levels of IFN-γ were quantified using IFN-γ Quantikine ELISA kits at 7 and 40 dpi (R&D Systems, Minneapolis, cat. no. MIF00), following the manufacturer’s instructions.
Histopathological studies
Samples of intestinal and muscle tissue were collected and preserved in 10% formalin. The samples were then washed, dehydrated using increasing concentrations of ethanol (70%, 90%, and 100%), and cleared with a mixture of ethanol and xylene. Samples were then immersed in pure xylene and embedded in paraffin wax. A microtome was employed to produce sections with a thickness of 5 μm. Sections were then stained with hematoxylin and eosin (Kiernan Reference Kiernan2015).
Immunohistochemical assessment
To evaluate B-cell lymphoma-2 (Bcl-2) and cyclooxygenase-2 (COX-2) protein expression, immunohistochemical staining was performed on intestinal and muscular tissues, respectively. The following antibodies were used: rabbit polyclonal anti-Bcl2 antibody (Abcam cat. no. ab59348) for intestinal sections and rabbit polyclonal anti-COX-2 antibody (Abcam cat. no. ab15191) for muscular sections. Antigen-antibody complexes were visualized using the avidin-biotin-peroxidase method. Negative controls were established by replacing the primary or secondary antibodies with nonimmune serum (Mohany et al. Reference Mohany, Ahmed and Al-Rejaie2022). Digital images captured via Leica DM500 microscope (Leica Microsystems, Germany) were analyzed using ImageJ v1.48 (version 1.48v National Institute of Health, Bethesda, Maryland, USA). The area percentage of immunoreactivity was quantified in intestinal and muscle sections.
Statistical analysis
The study utilized GraphPad Prism 8 software (California, USA) for statistical analysis. ANOVA and Tukey’s post hoc tests were utilized to determine statistical differences between groups, with statistical significance set at P < 0.05. Results were presented as mean ± standard deviation (SD).
Results
Antiparasitic effects
The mean number of adult worms showed a significant decline in all treated groups compared with the positive control group. The administration of A. sativum in GIV resulted in a significant reduction of the adult worm count (25.2 ± 4.7), demonstrating a drug efficacy of 39.7%. The combination of ABZ and A. sativum administered to GV demonstrated the highest drug efficacy, demonstrating a reduction percentage of 99.4% (0.4 ± 0.54). The treatment of infected mice significantly decreased the mean count of encysted larvae. The mean larval count in GII was 4158 ± 462.7. The administration of A. sativum in GIV resulted in a marked decrease in T. spiralis larval count (1898 ± 14.79) relative to GII (P < 0.001), indicating a therapeutic efficacy of 54.4%. The most notable decrease in mean larvae count occurred in GV, which received combination therapy (90.4 ± 33) with an efficacy of 97.8% (P < 0.001), followed by GIII (202 ± 23.87), exhibiting an efficacy of 95.14% (Table 1).
Mean adult T. spiralis count among the studied groups

n: number of mice; R: Reduction; SD: Standard deviation; P : probability; **:Highly significant difference
P1: GII compared to GIII, P2: GII compared to GIV, P3: GII compared to GV, P4: GIII compared to GIV, P5: GIII compared to GV, P6: GIV compared to GV
Biochemical findings
Serum IFN-γ levels
The treatment groups exhibited a notable increase in serum IFN-γ levels on 7 and 40 dpi, compared to the infected control groups (P < 0.001). In addition, there was a marked increase in GV receiving the combination of ABZ and A. sativum (Table 2).
Serum IFN-γ levels on day 7 and day 40 pi

n: number of mice; R: Reduction; SD: Standard deviation; P : probability; *: Significant difference; **: Highly significant difference
P1: GII compared to GIII, P2: GII compared to GIV, P3: GII compared to GV, P4: GIII compared to GIV, P5: GIII compared to GV, P6: GIV compared to GV
Histopathological results
Histopathological results at 7 dpi
Positive control intestine sections exhibited significant inflammatory infiltration in the core of the intestinal villi. Lymphocytes and plasma cells were the predominant inflammatory cells observed. Sections demonstrated broadening, distortion, and erosion of the intestinal villi (Figure 1a, b). Analysis of sections from various treated groups revealed a significant decrease in intestinal inflammation and restoration of intestinal villi architecture (Figure 1d–e). Group GV, which received the combination of ABZ and A. sativum, exhibited the most significant findings (Figure 1e).
Histopathological examination of the small intestine of the studied groups (H&E). (a) Positive control group exhibited dense inflammatory infiltrate within villous cores (red arrows), villous tip sloughing (grey arrows), and villous broadening. (b) The positive control group demonstrated T. spiralis adult cross-sections embedded within architecturally distorted villi (red arrows). (c) The ABZ-treated group displayed mild to moderate lymphoplasmacytic infiltration in villous cores (red arrows). (d) The A. sativum-treated group showed a moderate inflammatory infiltrate (red arrows). (e) ABZ and A. sativum combination group revealed restored villous architecture with minimal inflammation (red arrows) (X200).

Histopathological results at 40 dpi
Muscle sections from the infected control mice (GII) demonstrated abundant encysted T. spiralis larvae dispersed throughout the sarcoplasm, along with substantial chronic inflammatory infiltration, including lymphocytes, plasma cells, and histiocytes, surrounding larvae and disseminating within muscle bundles (Figure 2a, b). Treated groups demonstrated significant reductions in larval density and peri-larval inflammation. Group V (A. sativum + ABZ) showed the most pronounced decrease in inflammatory infiltrates.
Histopathological examination of the diaphragm of the studied groups (H&E). (a) Positive control group with multiple T. spiralis larvae embedded in musculature (grey arrow) and dense inflammatory infiltrate (red arrows). (b) Higher magnification of positive control showing dense plasma-lymphocytic infiltrate within muscle bundles (red arrow). (c) The ABZ-treated group exhibited mild peri-larval inflammation (red arrow). (d) The A. sativum-treated group demonstrated a moderate peri-larval inflammatory infiltrate (red arrows). (e) ABZ and A. sativum combination group displayed markedly reduced plasma-lymphocytic infiltration (red arrow) (200X for a and 400X for b–e).

Immunohistochemical results
On the 7th dpi, Bcl-2 immunohistochemistry of the positive control intestinal sections exhibited very few areas of weak cytoplasmic expression. Lining epithelial cells that express Bcl-2 exhibited a pale brownish color (Figure 3a). Treatment groups showed strong cytoplasmic Bcl-2 expression in epithelial cells and inflammatory infiltrates (Figure 3b–d). Muscle sections from infected controls revealed high COX-2 immunoreactivity (Figure 4a), while therapeutic groups displayed mild to moderate expression (Figure 4b–d). The combination group exhibited a marked reduction in COX-2 expression (Figure 4d). Figure 5 shows the area % of immunoreactivity of Bcl-2 and COX-2 in intestinal and muscle sections, respectively.
Immunohistochemical staining of Bcl-2 in the intestine of the studied groups. (a) The positive control group showed sparse, weak cytoplasmic Bcl-2 expression (red arrows) and epithelial ulceration (grey arrows). (b) The ABZ-treated group exhibited elevated Bcl-2 expression in the epithelial lining and interstitial inflammatory cells (red arrows). Regions devoid of expression exhibited a pale blue color (blue asterisk). (c) A. sativum treated group showed strong Bcl-2 expression (red arrows) and few non-reactive areas (blue asterisk). (d) The combination group of ABZ and A. sativum demonstrated a significant increase in Bcl-2 expression relative to the other groups (red arrows) (X400).

Immunohistochemical staining of COX-2 in the diaphragm of the studied groups. (a) Strong immunohistochemical expression of COX-2 was detected in positive control muscle sections (red arrows). (b) The ABZ-treated group exhibited decreased COX-2 expression in diaphragm myofibrils with a reduced intensity, which was demonstrated as a light brown color (red arrows). (c) A. sativum-treated group showed moderate expression of COX-2 in the inflammatory infiltrate surrounding T. spiralis larvae (red arrows). (d) The combination group of ABZ and A. sativum demonstrated minimal expression of COX-2 with reduced intensity of brown compared to the positive control (red arrows) (X400).

Bcl-2 and COX-2 immunoreactivity (area%).
(a) Bcl-2 immunoreactivity in the intestinal sections on the seventh dpi.
(b) COX-2 immunoreactivity in the diaphragm sections on the 40th dpi.
** means p < 0.001 versus the positive control group

Discussion
Numerous medicinal plants demonstrate significant therapeutic potential against diverse pathologies. They offer enhanced tolerability and reduced adverse effects compared to synthetic drugs, rendering them safe alternatives (Yadav and Temjenmongla Reference Yadav and Temjenmongla2012).
Although ABZ remains the first-line treatment for trichinellosis, severe side effects, including mortality risks, have been documented (Shalaby et al. Reference Shalaby, Moghazy, Shalaby and Nasr2010; Yadav and Temjenmongla Reference Yadav and Temjenmongla2012). To our knowledge, currently, there is limited research regarding the in vivo anti-T. spiralis properties of A. sativum. Therefore, the present study aimed to evaluate the in vivo antiparasitic, anti-inflammatory, and antiapoptotic effects of A. sativum on the adult and larval stages of T. spiralis and to compare its efficacy with that of ABZ. The mean adult and larval counts were assessed. Serum IFN-γ levels, along with histopathological and immunohistochemical analyses, were utilized to assess the efficacy of A. sativum.
The treatment groups demonstrated a significant reduction in adult and larval counts compared to the positive control. The group administered the combination of A. sativum and ABZ (GV) resulted in maximum reduction percentages of 99.4% and 97.8%. The administration of A. sativum (GIV) significantly reduced adult and larval counts by 39.7% and 54.4%, respectively, indicating enhanced efficacy during the muscle phase. In contrast, the efficacy of ABZ was more pronounced in the intestinal phase.
Numerous studies have shown that many of garlic’s characteristics are derived from allicin. The alliinase enzyme catalyzes the conversion of alliin to allicin (Borlinghaus et al. Reference Borlinghaus, Albrecht, Gruhlke, Nwachukwu and Slusarenko2014). The antimicrobial efficacy of allicin is due to its interaction with the thiol groups of enzymes, such as RNA polymerase and thioredoxin reductase (Moutia et al. Reference Moutia, Habti and Badou2018). Cysteine proteinase metabolism may be influenced by allicin, potentially hindering the pathogenicity of the parasite (Ankri and Mirelman Reference Ankri and Mirelman1999). Allicin, along with its chemically stable derivative diallyl trisulphide (DAT) and ajoene, inhibits the proliferation of certain parasites and impairs lipid and protein absorption within the parasite (Anthony et al. Reference Anthony, Fyfe and Smith2005). Some researchers have attributed the antiparasitic effects of A. sativum to its antioxidant capabilities and enhancing host defense against the parasite (Krstin et al. Reference Krstin, Sobeh, Braun and Wink2018; Moutia et al. Reference Moutia, Habti and Badou2018).
A. sativum has been extensively studied for its antihelminthic properties. The tegumental integrity and motility of T. spiralis adults and larvae were adversely affected. It resulted in a 100% mortality rate after 24 hours of incubation for muscle larvae and after 6 hours for the adult stage (Abou Hussien et al. Reference Abou Hussien, Faheem, Sweed and Ibrahim2022). The administration of alchinal, a mixture combining Echinacea purpurea extract, A. sativum extract, and cocoa, to T. spiralis-infected mice significantly reduced both adult and larval counts (Bany et al. Reference Bany, Zdanowska, Zdanowski and Skopińska-Rózewska2003). A significant reduction in S. mansoni adult worms was observed after in vitro incubation with allicin (Fakahany et al. Reference Fakahany, Abdelmaabood, Hamid, Morsi and Abououf2020). Garlic treatment significantly reduced both the size and quantity of Echinococcus granulosus cysts in infected mice (Qaemifar et al. Reference Qaemifar, Borji and Adhami2023). A. sativum demonstrated notable anthelmintic effectiveness against Ascaris suum and various other helminths in all pig categories (Băieş et al. Reference Băieş, Cotuţiu, Spînu, Mathe, Cozma-Petruț, Bolboacǎ, Engberg, Collin and Cozma2024). The immersion treatment using garlic extract demonstrated effectiveness against gill monogeneans while not adversely affecting Nile tilapia. An in vitro study demonstrated the antiparasitic potential against gill monogeneans (Reda et al. Reference Reda, Khalil, Elhady, Tayel and Ramadan2024).
Antiprotozoal efficacy of A. sativum was also reported. In culture, A. sativum showed equivalent efficacy to metronidazole against Trichomonas vaginalis (Ibrahim Reference Ibrahim2013). A. sativum essential oil’s anti-Toxoplasma properties were also reported in vitro and in vivo (Alnomasy Reference Alnomasy2021). Compared to metronidazole, A. sativum preparation showed more anti-giardial efficacy regarding the reduction of Giardia cyst count and viability in the experimentally infected hamsters (Eissa et al. Reference Eissa, Abdel-Shafi, El-Sayed, Negm and Ahmed2022). A. sativum essential oil demonstrated substantial inhibitory effects on the developing stages of Leishmania amazonensis. It decreased the parasite burden in macrophages (Garcia et al. Reference Garcia, Amorim, Amaral, da Cruz, Vermelho, Nico and Rodrigues2023).
Cytokines modulate the immune response effectively. IFN-γ and other TH1-associated cytokines stimulate cellular immune response (Liu and Uzonna Reference Liu and Uzonna2012). Parasitic infection results in macrophage activation, leading to the production of TNF-α and the synthesis of IFN-γ. IFN-γ reduces both infection duration and parasite load. It effectively eliminated parasites such as Leishmania (Lopes et al. Reference Lopes, Costa-da-Silva and DosReis2014). IFN-γ significantly influences the adaptive immune response and is essential for innate immunity against parasites (Petry et al. Reference Petry, Jakobi and Tessema2010). The A. sativum group exhibited a significant increase in serum IFN-γ levels compared to the positive control group in the biochemical assessment. Administering A. sativum at these doses appears to facilitate a transition toward the Th1 response in mice infected with trichinellosis. The findings of this study align with those of Liu et al. (Reference Liu, Su, Lii and Sheen2009), who examined the effects of garlic oil on Th1 and Th2 cells and observed an increased ratio of IFN-γ to IL-4 following garlic oil administration (Liu et al. Reference Liu, Su, Lii and Sheen2009). A study assessing the efficacy of black garlic on tumor cells revealed that garlic extracts enhance the production of IFN-γ, TNF-α, and IL-2 by Th1 lymphocytes and macrophages (Sasaki et al. Reference Sasaki, Lu, Machiya, Tanahashi and Hamada2007). The administration of A. sativum methanolic extract to mice with cystic echinococcosis led to a significant increase in IFN-γ serum levels compared to the albendazole study group (Shirgholami et al. Reference Shirgholami, Borji, Mohebalian and Heidarpour2021). The treatment with A. sativum also resulted in increased IFN-γ serum levels in both immunocompetent and immunosuppressed mice infected with Cryptosporidium parvum compared to the control groups (Farid et al. Reference Farid, Yousry and Safwat2022). One possible explanation for A. sativum’s immune-boosting effects is the presence of its water-soluble compound S-allyl-L-cysteine (Jones et al. Reference Jones, Collin, Tregova, Trueman, Brown, Cosstick, Hughes, Milne, Wilkinson, Tomsett and Thomas2007). In our study, ABZ treatment increased IFN-γ serum levels during both the intestinal and muscle phases. This finding elucidates potential immune-mediated mechanisms of ABZ beyond its established direct impact on parasite β-tubulin. In contrast, Abou Rayia et al. (Reference Abou Rayia, Izzularab, Harras, Ghafar, Azzam, Harras, Younis, Soliman and Saad2023) reported a significant reduction of IFN-γ serum levels in the ABZ-treated group during the muscle phase (Abou Rayia et al. Reference Abou Rayia, Izzularab, Harras, Ghafar, Azzam, Harras, Younis, Soliman and Saad2023).
Histopathological examination of small intestine sections from infected untreated mice demonstrated significant inflammatory cellular infiltration within the villous core. The intestinal villi exhibited broadening and degeneration. Additionally, sections of T. spiralis adults were identified, resulting in distortion of the villous architecture. The positive control muscle sections displayed significant numbers of encysted T. spiralis larvae distributed throughout the muscle bundles, accompanied by a notable inflammatory infiltrate. Several previous studies have reported comparable findings (Elgendy et al. Reference Elgendy, Othman, Hasby Saad, Soliman and Mwafy2020; Elmehy et al. Reference Elmehy, Ismail, Soliman, Amer, Elkaliny, El-Ebiary and Gamea2021). The group administered the combination of A. sativum and ABZ (GV) demonstrated the most significant improvement in villous architecture and a marked reduction in inflammation. The muscle sections of the combination group exhibited the fewest larvae with localized pericapsular plasma-lymphocytic inflammatory cellular infiltrate.
Previous research demonstrated an improvement in histological changes in groups administered A. sativum across various disease models. Immunocompromised mice infected with Cryptosporidium parvum and treated with A. sativum showed significant improvement in intestinal histology, as indicated by nearly normal intestinal villi and a substantial reduction in inflammatory infiltration (Farid et al. Reference Farid, Yousry and Safwat2022). In a rat model exhibiting cisplatin-induced hepatorenal damage, the administration of garlic oil resulted in notable histopathological improvements (Abdel-Daim et al. Reference Abdel-Daim, Abdel-Rahman, Dessouki, El-Far, Khodeer, Bin-Jumah, Alhader, Alkahtani and Aleya2020). In the amoebiasis rat model, allicin markedly diminished liver injury and central vein congestion (Hussein et al. Reference Hussein, AL-Abady and Saleh2023). Our findings align with previous research indicating the anti-inflammatory properties of A. sativum as it markedly reduced alveolar inflammatory infiltration in a rat model of smoking (Savira et al. Reference Savira, Sari, Machrina, Widjaja, Unitly, Ilyas, Siregar, Pandia, Rusda and Amin2023). Multiple studies indicate a significant decrease in inflammatory markers among groups treated with A. sativum (Almatroodi et al. Reference Almatroodi, Anwar, Almatroudi, Khan, Alrumaihi, Alsahli and Rahmani2020; Ansary et al. Reference Ansary, Forbes-Hernández, Gil, Cianciosi, Zhang, Elexpuru-Zabaleta, Simal-Gandara, Giampieri and Battino2020). The anti-inflammatory activity of A. sativum is attributed to its antioxidant properties, which resolve the oxidative stress associated with T. spiralis. The therapeutic effects of garlic may stem from its capacity to scavenge reactive oxygen species (ROS) that trigger lipid peroxidation. This intervention decreases malondialdehyde levels while enhancing total glutathione and superoxide dismutase (Badr and Al-Mulhim Reference Badr and Al-Mulhim2014). Garlic’s anti-inflammatory effect is further augmented by allicin’s ability to inhibit TNF-α secretion (Lang et al. Reference Lang, Lahav, Sakhnini, Barshack, Fidder, Avidan, Bardan, Hershkoviz, Bar-Meir and Chowers2004).
Bcl-2 family members regulate the release of essential pro-apoptotic and antiapoptotic polypeptides to govern this process (Hockenbery et al. Reference Hockenbery, Oltvai, Yin, Milliman and Korsmeyer1993). Bcl-2 is a significant antiapoptotic protein essential for apoptosis regulation (Lu et al. Reference Lu, Zheng, Zhang, Cong, Guo, Zhang, Zhang, Long, Liu, Wang and Cui2025). Interfering with Bcl-2’s normal function can lead to the formation of mitochondrial pores, facilitating the release of cytochrome C and other pro-apoptotic factors (Babal et al. Reference Babal, Milcheva, Petkova, Janega and Hurnikova2011). Antiapoptotic members, such as Bcl-2, neutralize apoptotic factors through binding, particularly with cytochrome C (Cory et al. Reference Cory, Huang and Adams2003). Bcl-2 increases cellular antioxidant capacity, thus preventing apoptosis induced by oxidative stress (Hockenbery et al. Reference Hockenbery, Oltvai, Yin, Milliman and Korsmeyer1993).
The positive control group in this study demonstrated minimal expression of Bcl-2 in intestinal tissues. The downregulation of Bcl-2 in trichinellosis may result from interactions between the gut epithelium and second-stage larval excretory/secretory proteins, leading to enterocyte apoptosis and larval invasion (Lu et al. Reference Lu, Zheng, Zhang, Cong, Guo, Zhang, Zhang, Long, Liu, Wang and Cui2025). The reduced expression of Bcl-2 may also be attributed to exosome-delivered miR-153 (Wang et al. Reference Wang, Lin, Han, Li, Zhen, Zhang, Sun and Lu2023). The present study revealed elevated Bcl-2 expression in the intestinal tissue of the ABZ-treated group relative to the infected untreated group. This result is consistent with the findings of Fadl et al. (Reference Fadl, Amin, Wanas, El-Din, Ibrahim, Aboulhoda and Bocktor2020). Increased expression of the Bcl-2 gene was observed in the abomasum tissue of goats experimentally infected with Haemonchus contortus and treated with ABZ (Sedky et al. Reference Sedky, Abd El-Aziz, Nasr, Abdel-Aziem, Hassan, Mohamed and Abou Zeina2024). The elevated expression of Bcl-2 in group 3 treated with A. sativum is likely due to allicin, its main component, indicating its role in modulating the mitochondrial-mediated apoptotic signaling pathway (Wu et al. Reference Wu, Li, Song, Li, Bai, Liu, Han, Xu, Li, Zhang, Wang and Fan2017). This is consistent with the findings of Elsayed et al. (Reference Elsayed, Gad, Elkamar and Ahmed2022), who reported elevated Bcl-2 expression in rats with induced hepatotoxicity and administered garlic oil.The antioxidant properties of garlic were linked to the increased expression of Bcl-2. In contrast, fresh garlic juice decreased Bcl-2 expression in squamous cell carcinoma (Farhadi et al. Reference Farhadi, Jahanpour, Hazem, Aghbali, Baradran and Vahid Pakdel2015). S-allyl cysteine, a garlic derivative, reduced Bcl-2 expression in ovarian cancer cells in in vitro research (Xu et al. Reference Xu, Feng, Zhang, Zhang, Luo, Su and Lin2014).
COX-2 (prostaglandin-endoperoxide synthase) is a membrane-bound protein that regulates the conversion of arachidonic acid to prostaglandins. The present study demonstrated a reduction in COX-2 expression within the muscle tissues of the treatment groups. The combination group exhibited a significant reduction in COX-2 expression relative to the infected control group. Various studies have demonstrated the anti-inflammatory effects of A. sativum via the downregulation of COX-2 expression. The hydroalcoholic extract of garlic inhibited LPS-induced COX-2 expression in a murine model of ulcerative colitis (Recinella et al. Reference Recinella, Gorica, Chiavaroli, Fraschetti, Filippi, Cesa, Cairone, Martelli, Calderone, Veschi, Lanuti, Cama, Orlando, Ferrante, Menghini, Di Simone, Acquaviva, Libero, Nilofar and Leone2022). It also exhibited cardioprotective effects by decreasing mRNA levels of COX-2 and other inflammatory biomarkers (Recinella et al. Reference Recinella, Chiavaroli, Masciulli, Fraschetti, Filippi, Cesa, Cairone, Gorica, De Leo, Braca, Martelli, Calderone, Orlando, Ferrante, Menghini, Di Simone, Veschi, Cama, Brunetti and Leone2021).
Conclusion and recommendations
The anti-inflammatory and immunomodulatory properties of A. sativum establish its efficacy as a natural therapeutic agent against trichinellosis. Further studies are recommended to standardize the dosage for maximum anti-trichinosis efficacy. A. sativum exhibited enhanced therapeutic efficacy during the muscular phase of infection, thereby positioning it as a promising future treatment for T. spiralis infection. A. sativum increased IFN-γ; hence, we propose it may possess an immunomodulatory function in trichinosis, necessitating more research. We recommend further studies to clarify the molecular mechanisms behind the activity of A. sativum in trichinellosis and to isolate its bioactive ingredients for enhanced therapeutic efficacy without adverse effects.
Financial support
None.
Competing interests
The authors declare no conflict of interest.
Ethical standard
The experiment was approved by the Faculty of Medicine and the Institutional Animal Care and Use Committee of Zagazig University (Committee approval number: ZU-IACUC/3/F/256/2023).
